Overview
Dung Le, M.D. is a professor of oncology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Her research interests include novel approaches to patients with gastrointestinal malignancies. She has served as the principal investigator (PI) on many clinical trials focused on testing immunotherapy in patients with gastrointestinal malignancies and she has also served as the national PI on several studies including: anti-programmed death-1 (PD-1) in tumors with mismatch repair deficiency; a clinical trial in advanced pancreatic cancer patients evaluating the safety, tolerability and immune response to CRS-207, a listeria vaccine platform which has been modified to express the tumor antigen mesothelin; a multi-center, phase 2 study testing CRS-207 as a boost to allogenic pancreatic tumor cells transfected with GM-CSF gene (GVAX) for treatment of advanced pancreatic adenocarcinoma (PDA); a trial testing GVAX/ipilimumab in the maintenance setting for metastatic pancreatic cancer; and GVAX/CRS-207 +/- nivolumab in metastatic pancreatic cancer. These studies incorporate extensive laboratory correlates and have involved collaborations with clinicians and bench scientists with expertise in the fields of immunotherapy and cancer genomics.
Dr. Le is rated as an Experienced provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer.
Her clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
201 North Broadway Street, Viragh BLDG 5th FL, Viragh BLDG 5th FL, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Lutherville Hematology And Oncology Services
Sandy Kotiah is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Kotiah is rated as a Distinguished provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Neuroendocrine Tumor, Paget Disease of the Breast, Anemia, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Kotiah is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Ana De Jesus is an Oncologist in Baltimore, Maryland. Dr. De Jesus is rated as a Distinguished provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
University Of Maryland Oncology Associates PA
Petr Hausner is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Hausner is rated as a Distinguished provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, and Anal Cancer. Dr. Hausner is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Pancreatic CancerDr. Le isElite. Learn about Pancreatic Cancer.
- Distinguished
- Colorectal CancerDr. Le isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Le isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Le isDistinguished. Learn about Familial Pancreatic Cancer.
- Gastroesophageal Junction CancerDr. Le isDistinguished. Learn about Gastroesophageal Junction Cancer.
- Neuroendocrine TumorDr. Le isDistinguished. Learn about Neuroendocrine Tumor.
- Advanced
- Ampullary CancerDr. Le isAdvanced. Learn about Ampullary Cancer.
- Lynch SyndromeDr. Le isAdvanced. Learn about Lynch Syndrome.
- PancreatoblastomaDr. Le isAdvanced. Learn about Pancreatoblastoma.
- Experienced
- Anal CancerDr. Le isExperienced. Learn about Anal Cancer.
- Bone TumorDr. Le isExperienced. Learn about Bone Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)
- Endometrial CancerDr. Le isExperienced. Learn about Endometrial Cancer.
- Gallbladder AdenocarcinomaDr. Le isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Le isExperienced. Learn about Gallbladder Cancer.